About us
Bicycle Therapeutics is developing a brand new class of small, chemically synthesised medicines, called Bicycles.
Our Vision
To redefine what’s possible for people with cancer and other diseases.
Our Story
We were founded in 2009 based on innovative science conducted in the laboratory of Sir Greg Winter, a pioneer in monoclonal antibodies, to translate our first-in-class Bicycles into transformative medicines for life-altering diseases. We are a transatlantic company, with headquarters in Cambridge, U.K., and many key functions and members of our leadership team located in the biotech hub of Boston, Mass.
Our Team
We are experienced leaders who are driven by a common goal – to develop a novel class of therapies for diseases where existing treatment options are limited.
Kevin Lee, Ph.D., MBA
Ros Deegan, MBA
Lee Kalowski, MBA
Nick Keen, Ph.D.
Maria Koehler, M.D., Ph.D.
Gillian Langford, Ph.D.
Peter U. Park, Ph.D.
Michael Skynner, Ph.D.
